These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33691749)

  • 1. Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment.
    Oliver J; Nair N; Orozco G; Smith S; Hyrich KL; Morgan A; Isaacs J; Wilson AG; ; Barton A; Plant D
    Arthritis Res Ther; 2021 Mar; 23(1):80. PubMed ID: 33691749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samples.
    Smith SL; Eyre S; Yarwood A; Hyrich K; Morgan AW; Wilson AG; Isaacs J; ; Plant D; Barton A
    Arthritis Res Ther; 2015 Dec; 17():359. PubMed ID: 26667261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.
    Smolen JS; Burmester GR; Combe B; Curtis JR; Hall S; Haraoui B; van Vollenhoven R; Cioffi C; Ecoffet C; Gervitz L; Ionescu L; Peterson L; Fleischmann R
    Lancet; 2016 Dec; 388(10061):2763-2774. PubMed ID: 27863807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
    Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A
    Front Immunol; 2019; 10():1459. PubMed ID: 31312201
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiomics and Machine Learning Accurately Predict Clinical Response to Adalimumab and Etanercept Therapy in Patients With Rheumatoid Arthritis.
    Tao W; Concepcion AN; Vianen M; Marijnissen ACA; Lafeber FPGJ; Radstake TRDJ; Pandit A
    Arthritis Rheumatol; 2021 Feb; 73(2):212-222. PubMed ID: 32909363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis.
    Smith SL; Alexander S; Nair N; Viatte S; Eyre S; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; Plant D; Barton A
    Ann Rheum Dis; 2023 May; 82(5):611-620. PubMed ID: 36810200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis.
    Badot V; Galant C; Nzeusseu Toukap A; Theate I; Maudoux AL; Van den Eynde BJ; Durez P; Houssiau FA; Lauwerys BR
    Arthritis Res Ther; 2009; 11(2):R57. PubMed ID: 19389237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis.
    Krintel SB; Essioux L; Wool A; Johansen JS; Schreiber E; Zekharya T; Akiva P; Ostergaard M; Hetland ML
    PLoS One; 2012; 7(6):e38539. PubMed ID: 22685579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
    Palmowski A; Strehl C; Pfeiffenberger M; Häupl T; Schad M; Kallarackal J; Prothmann U; Dammann D; Bonin M; Brandt A; Schneider U; Gaber T; Buttgereit F
    Clin Rheumatol; 2024 Jan; 43(1):511-519. PubMed ID: 37978145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy.
    Oliveira RD; Fontana V; Junta CM; Marques MM; Macedo C; Rassi DM; Passos GA; Donadi EA; Louzada-Junior P
    J Rheumatol; 2012 Aug; 39(8):1524-32. PubMed ID: 22753658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis.
    Fleischmann RM; Blanco R; Hall S; Thomson GTD; Van den Bosch FE; Zerbini C; Bessette L; Enejosa J; Li Y; Song Y; DeMasi R; Song IH
    Ann Rheum Dis; 2021 Apr; 80(4):432-439. PubMed ID: 33148701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients.
    Hageman I; Mol F; Atiqi S; Joustra V; Sengul H; Henneman P; Visman I; Hakvoort T; Nurmohamed M; Wolbink G; Levin E; Li Yim AYF; D'Haens G; de Jonge WJ
    Front Immunol; 2023; 14():1303231. PubMed ID: 38187379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study.
    Ortea I; Roschitzki B; López-Rodríguez R; Tomero EG; Ovalles JG; López-Longo J; de la Torre I; González-Alvaro I; Gómez-Reino JJ; González A
    PLoS One; 2016; 11(4):e0153140. PubMed ID: 27050469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis.
    Yoosuf N; Maciejewski M; Ziemek D; Jelinsky SA; Folkersen L; Müller M; Sahlström P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
    Rheumatology (Oxford); 2022 Apr; 61(4):1680-1689. PubMed ID: 34175943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapy.
    Sutcliffe M; Nair N; Oliver J; Morgan AW; Isaacs JD; Wilson AG; Verstappen SMM; Viatte S; Hyrich KL; Morris AP; Barton A; Plant D
    Rheumatology (Oxford); 2022 Nov; 61(12):4935-4944. PubMed ID: 35377444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in the metabolome in response to disease activity of rheumatoid arthritis.
    Tatar Z; Migne C; Petera M; Gaudin P; Lequerre T; Marotte H; Tebib J; Pujos Guillot E; Soubrier M
    BMC Musculoskelet Disord; 2016 Aug; 17(1):353. PubMed ID: 27549132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study.
    Hirata S; Li W; Defranoux N; Cavet G; Bolce R; Yamaoka K; Saito K; Tanaka Y
    Mod Rheumatol; 2015 May; 25(3):344-9. PubMed ID: 25295918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial Inflammatory Pathways Characterize Anti-TNF-Responsive Rheumatoid Arthritis Patients.
    Wang J; Conlon D; Rivellese F; Nerviani A; Lewis MJ; Housley W; Levesque MC; Cao X; Cuff C; Long A; Pitzalis C; Ruzek MC
    Arthritis Rheumatol; 2022 Dec; 74(12):1916-1927. PubMed ID: 35854416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies.
    Bitoun S; Hässler S; Ternant D; Szely N; Gleizes A; Richez C; Soubrier M; Avouac J; Brocq O; Sellam J; de Vries N; Huizinga TWJ; Jury EC; Manson JJ; Mauri C; Matucci A; Hacein Bey Abina S; Mulleman D; Pallardy M; Broët P; Mariette X;
    JAMA Netw Open; 2023 Jul; 6(7):e2323098. PubMed ID: 37436748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study.
    Fleischmann R; Goldman JA; Leirisalo-Repo M; Zanetakis E; El-Kadi H; Kellner H; Bolce R; DeHoratius R; Wang J; Decktor D
    Curr Med Res Opin; 2014 Nov; 30(11):2139-49. PubMed ID: 25050591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.